BSG and primary cutaneous T-cell non-Hodgkin lymphoma: The anti-CD147 antibody was found to suppress the proliferation of CTCL tumor cell lines through the downregulation of phosphorylated extracellular-regulated kinase 1/2 and Akt [5].